CME-MOC Webinar Series to Update Clinicians on Latest in NASH…
NASH (non-alcoholic steatohepatitis) is a liver disorder characterized by accumulation of fat in the liver and liver scarring. It…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2022
Michigan Makes Changes to Laws Surrounding Pharmacy Benefit Managers
In mid-February 2022, Michigan Governor Gretchen Whitmer signed several pharmacy benefit manager (PBM) reforms into law, including…
Teva Reaches $225 Million Settlement with Texas Over Opioid Claims
On Monday, February 14, 2022, Texas Attorney General Ken Paxton announced a $225 million settlement with Teva Pharmaceutical…
Pharmacists’ Role to Expand Over the Next Decade
According to recent research from the Columbia University Mailman School of Public Health and Express Scripts Pharmacy,…
MedPAC Presents MA Findings, Including Increased Spending
In mid-January 2022, MedPAC held its public meeting virtually via GoToWebinar, where the Commission covered a multitude of topics,…
Ten Individual Indicted in $300 Million Healthcare Fraud
Earlier this year, Chad E. Meacham, United States Attorney for the Northern District of Texas, announced a $300 million healthcare…
Diagnostic Company Reaches False Claims Act Settlement
In mid-February 2022, American Health Associates, Inc. (AHA) reached an agreement with the United States Department of Justice…
OPDP Sends “Bad Ad” Warning Letter over PARAGARD Video
On February 12, 2021, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a…
California Court Rules that FMV Payments Can Qualify as Illegal Kickbacks
On February 23, 2022, the United States District Court for the Central District of California denied Medtronic’s motion to dismiss…
Mallinckrodt Reaches $260 Million Anti-Kickback Settlement
Recently, Mallinckrodt ARD LLC reached a $260 million settlement to resolve allegations that Mallinckrodt violated the False…